CPS Technologies (NASDAQ:CPSH – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday. A number of other analysts have also weighed in on CPSH. Weiss Ratings reiterated a “sell (d-)” rating on shares of CPS Technologies in a […]

Magna International (NYSE:MGA – Get Free Report) (TSE:MG) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. Other research analysts also recently issued research reports about the stock. Evercore ISI raised their target price on […]

Heritage Commerce (NASDAQ:HTBK – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other research firms have also weighed in on HTBK. Piper Sandler lifted their price objective on shares of Heritage Commerce from […]

Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Other equities research analysts have also recently issued reports about the company. Lifesci Capital upgraded Amylyx Pharmaceuticals to a “strong-buy” rating in a research […]

The RMR Group (NASDAQ:RMR – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Sunday. A number of other brokerages have also weighed in on RMR. Weiss Ratings reissued a “sell (d+)” rating on shares of The RMR Group […]

Intrusion (NASDAQ:INTZ – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. A number of other research firms have also weighed in on INTZ. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Intrusion in a research report […]

Acadia Realty Trust (NYSE:AKR – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. Other equities research analysts also recently issued research reports about the stock. Truist Financial reduced their price objective on shares […]

RPC (NYSE:RES – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday. Other equities research analysts have also recently issued reports about the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of RPC in a research note on Monday, […]

Expedia Group (NASDAQ:EXPE – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Saturday. Several other research firms have also issued reports on EXPE. BNP Paribas initiated coverage on Expedia Group in a report on Monday, November 24th. […]

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. Other research analysts have also recently issued reports about the stock. Weiss Ratings restated a “sell (d-)” rating on shares of […]

Life360 (NASDAQ:LIF – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Other equities research analysts have also issued research reports about the stock. DA Davidson assumed coverage on shares of Life360 in […]

QUALCOMM (NASDAQ:QCOM – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Tuesday. QCOM has been the topic of a number of other research reports. Rosenblatt Securities reissued a “buy” rating and issued a $225.00 target price on shares of QUALCOMM […]

PDD (NASDAQ:PDD – Get Free Report) was downgraded by equities research analysts at Arete from a “buy” rating to a “neutral” rating in a research note issued on Tuesday. They presently have a $130.00 price target on the stock. Arete’s target price would indicate a potential upside of 10.98% from the company’s current price. PDD […]